LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 56.24 | 17.25 | 7011 | 4929 | 1.4224 | 1.0883 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.21 | 17.25 | 504 | 4942 | 0.1020 | 0.5120 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.21 | 17.25 | 8075 | 4942 | 1.6338 | 1.1240 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.21 | 17.25 | 7 | 4942 | 0.0014 | -0.1046 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.21 | 17.25 | 7549 | 4942 | 1.5274 | 1.1065 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 60.18 | 17.25 | 412 | 5031 | 0.0819 | 0.4733 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 60.18 | 17.25 | 8437 | 5031 | 1.6768 | 1.1303 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 60.18 | 17.25 | 8 | 5031 | 0.0016 | -0.0896 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 60.18 | 17.25 | 8004 | 5031 | 1.5908 | 1.1167 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.15 | 17.25 | 135 | 5061 | 0.0267 | 0.2853 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.15 | 17.25 | 8926 | 5061 | 1.7637 | 1.1434 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.15 | 17.25 | 9 | 5061 | 0.0018 | -0.0763 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.15 | 17.25 | 8472 | 5061 | 1.6740 | 1.1297 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 65.12 | 17.25 | 95 | 5095 | 0.0186 | 0.2311 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 65.12 | 17.25 | 9343 | 5095 | 1.8337 | 1.1534 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 65.12 | 17.25 | 5 | 5095 | 0.0010 | -0.1401 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 65.12 | 17.25 | 8832 | 5095 | 1.7334 | 1.1387 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 67.09 | 17.25 | 48 | 5221 | 0.0092 | 0.1322 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 67.09 | 17.25 | 9729 | 5221 | 1.8634 | 1.1569 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 67.09 | 17.25 | 5 | 5221 | 0.0010 | -0.1395 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 67.09 | 17.25 | 9127 | 5221 | 1.7481 | 1.1402 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 69.06 | 17.25 | 26 | 5242 | 0.0050 | 0.0510 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 69.06 | 17.25 | 9998 | 5242 | 1.9071 | 1.1628 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 69.06 | 17.25 | 5 | 5242 | 0.0010 | -0.1394 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 69.06 | 17.25 | 9532 | 5242 | 1.8182 | 1.1504 | MN20160310_N02 | K13 |